Lee Gary K.
Lyell Immunopharma, Inc. · Chief Scientific Officer
Lee Gary K. is listed in filings as Chief Scientific Officer at Lyell Immunopharma, Inc.. This profile follows SEC Form 4 activity through Feb 12, 2026, including sale activity. Recent filings connect the profile to Lyell Immunopharma, Inc. (LYEL). The current snapshot covers public activity from Feb 26, 2025 to Feb 12, 2026. Reported amounts are shown as $39.1K to $3.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $39k1.7k shares | SellFeb 11, 2026 | $23.39 | $12.92 |